Navigation Links
AMERIGROUP Names Linda Whitley-Taylor as Executive Vice President, Associate Services
Date:1/29/2008

her international experience, Whitley-Taylor has significant expertise in talent development and people strategy initiatives and is a Six Sigma Master Black Belt. In her role with AMERIGROUP, she will report directly to Carlson as a member of the Company's senior executive team.

Stredler and Mellon enter newly created positions. Stredler reports to Stanley F. Baldwin, AMERIGROUP Executive Vice President, General Counsel and Secretary. Mellon reports to John E. Littel, Executive Vice President, External Relations.

"Jeff Stredler and Bill Mellon both are outstanding professionals and veteran leaders who have distinguished themselves within their areas of expertise," Carlson said. "What's important for AMERIGROUP -- and those audiences we serve -- is that we are adding key executives who will contribute to our ability to grow both internally and externally."

As Senior Vice President, Senior Litigation Counsel, Stredler will be responsible for assisting the Company with legal matters. Prior to joining AMERIGROUP, he was a partner at the law firm of Williams Mullen, where he served as co-chair of litigation for the firm's Norfolk, Va., office. In 2006, Stredler was named one of Virginia's "Super Lawyers" by Virginia Super Lawyer magazine. In 2006 and 2007, he was recognized among the "Legal Elite" by Virginia Business magazine. Stredler received both his undergraduate degree and his law degree from the University of Virginia.

As Senior Vice President, Corporate Communications, Mellon will oversee all aspects of the Company's communications efforts, reaching not only its 4,200 employees and more than 1.7 million members, but also the additional audiences increasingly relying on AMERIGROUP as a leader in the field of caring for the financially vulnerable, seniors and people with disabilities. Previously, Mellon was Managing Director of Corporate Communications for Northwest Airlines. Prior to Northwest, Mellon served as Vice President, Public R
'/>"/>

SOURCE AMERIGROUP Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. AMERIGROUP to Acquire Memphis Health Plan
2. AMERIGROUP Corporation to Host Investor Day
3. AMERIGROUP Names Mary McCluskey, MD, Chief Medical Officer
4. AMERIGROUP Contracts with Federal Government to Offer Medicare Advantage Health Plans in Seven States
5. AMERIGROUP Corporation to Discuss Third Quarter Earnings on October 25
6. AMERIGROUP to Participate in National Disability Mentoring Day
7. AMERIGROUP Corporation to Present at the 2007 Credit Suisse Healthcare Conference on November 13
8. AMERIGROUP Corporation to Present at the Merrill Lynch Health Services Investor Conference on November 27
9. AMERIGROUP Community Care Provides Doctors Office Makeover in Houston
10. AMERIGROUP Foundation Awards $100,000 to Grady Health System Foundation in Atlanta
11. AMERIGROUP Community Care of Georgia Wins New Health Plan Accreditation from NCQA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)NEW YORK, Dec. 4 Care Investment Trust Inc. (NYSE: CRE ) ("Care" or the "Company") today announced that its Board of Directors has declared a dividend of $0.17 per share of common stock. The div
(Date:12/4/2009)SCOTTSDALE, Ariz., Dec. 4 Healthcare Trust of America, Inc. ("HTA"), a self-managed, non-traded, real estate investment trust, announced the execution of a purchase and sale agreement to acquire a th
(Date:12/4/2009)WASHINGTON, Dec. 4 In response to the U.S. Justice Department Drug Enforcement Agency,s (DEA) classification of boldione, desoxymethyltestosterone, and 19-nor-4,9(10)-androstadienedione as "anabolic
(Date:12/4/2009)More than 15 million Americans are recruited annually to participate in clinical trials according to the Alliance for Human Research Protection (AHRP), and most will be compensated for their participa
(Date:12/4/2009)Move a response to pressure from federal regulators to crack down on abuse of opioid medications , , FRIDAY, Dec. 4 (HealthDay News) -- The makers of 24 different prescription painkillers on F
Breaking Medicine News(10 mins):Health News:Care Investment Trust Inc. Declares Quarterly Dividend of $0.17 Per Share 2Health News:Healthcare Trust of America, Inc. Executes Agreement to Acquire a 92,500 Square Foot Medical Office Portfolio Located in Texas and Indiana 2Health News:Natural Products Association Issues Statement on DEA's Steroid Classification Action 2Health News:Human guinea pigs wary of high-paying medical trials 2Health News:Makers of Powerful Painkillers Present Safety Plans 2
...Va., April 29 The National,Alliance on Mental Ill...,Depression, about major depression in women, addr... It can be downloaded at, http://www.nami.org/wome...dle-aged Hispanic women have the highest rate of d...
...Conn., April 27 Therap Services, a service,bureau...ons to,organizations working with people with deve...r Therap users in Delaware in association with the...l conference is designed for residential directors...
...sue 10-Day Notice of Unfair Labor Practice Strike,...Kaiser Permanente hospitals are ramping up their f...day notice of an unfair labor practice strike,in C... threatening, intimidating, and spying on workers ...
...ukovich, director of the Governor,s Southwest Regi... at 1 p.m. on Monday, April 28, in,Farrell to call... for the,uninsured., Kukovich will be joined by l... join legislative and local government,officials a...
...re to negotiate major improvements, California Nur...l 25 Registered nurses at,Scripps Memorial Hospit...iation (CNA) as their union in an election this we... "Scripps nurses, vote to oust the CNA should be ...
...ch., April 25 The Michigan,Chamber of Commerce to...overage mandate that may find its way to the Novem...egislature to design and pass a universal,health c... job providers and taxpayers would need to write a...
Other Medicine News:Health News:NAMI: Women and Depression; 1 in 8 in Their Lifetime; Twice the Rate of Men 2Health News:Therap Services to Host Conference in Association with the Delaware Division of Developmental Disabilities Services 2Health News:Inter-Con Security Officers to Launch Strikes at Kaiser Hospitals Across California 2Health News:Scripps Memorial Hospital Nurses Throw Out CNA 2Health News:Michigan Chamber of Commerce Opposes 'Blank Check' Healthcare Ballot Proposal 2
(Date:12/3/2009)DOYLESTOWN, Pa., Dec. 3 Ted Karkus, Chairman and CEO of The Quigley Corporation, (Nasdaq: QGLY ) www.quigleyco.com announced today that the Company has completed its evaluation of its opportunitie
(Date:12/3/2009)WARRENDALE, Pa., Dec. 3 Radiology imaging leader MEDRAD, Inc. demonstrated PACS* injection-record integration capabilities at the November 2009 Radiology Society of North America in Chicago. The Co
(Date:12/3/2009)HOERSHOLM, Denmark and SAN DIEGO, California, December 3 , - SPC3649 Successfully Inhibits miR-122, a microRNA Important for,Hepatitis C Viral Replication, Thereby Significantly Reducing Hepatiti
Breaking Medicine Technology:Quigley CEO, Ted Karkus, Announces Phase One of 2010 Strategic Plan; Karkus Reports that the Primary Focus will be on Leveraging its OTC Platform; Company Aggressively Seeking Product Acquisitions and Line Extensions which Leverage its Distribution 2Quigley CEO, Ted Karkus, Announces Phase One of 2010 Strategic Plan; Karkus Reports that the Primary Focus will be on Leveraging its OTC Platform; Company Aggressively Seeking Product Acquisitions and Line Extensions which Leverage its Distribution 3MEDRAD Demonstrates PACS Injection-Record Integration at RSNA 2009 2MEDRAD Demonstrates PACS Injection-Record Integration at RSNA 2009 3New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 2New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 3New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 4New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 5Scientists find that individuals in vegetative states can learn 9986 1Scientists find that individuals in vegetative states can learn 9986 2New Chemo Regimen May Benefit Ovarian Cancer Patients 57711 1New Chemo Regimen May Benefit Ovarian Cancer Patients 57711 2U of C alumnus finds high numbers of heat loving bacteria in cold Arctic Ocean 9984 1U of C alumnus finds high numbers of heat loving bacteria in cold Arctic Ocean 9984 2
... inhibitor, and R7128, nucleoside polymerase inhib...load in patients with hepatitis C - , , NUTLEY, ... 25 Roche, InterMune, Inc. (Nasdaq: ITMN ) and ...irst results from their innovative, interferon-fre...tion therapy for the treatment of patients chronic...
...ion milestone payment to Pharmasset , , PRINCETON... ) and Roche (Roche SWX: RO, ROG; Pink Sheets: RHH...n dosed in a Phase IIb study of R7128, the nucleos...ent for the treatment of chronic hepatitis C (HCV)... treatment of R7128 in combination with Roche,s PE...
Other Medicine Technology:Ground-Breaking Combination of All-Oral Agents Demonstrates Potential as Hepatitis C Treatment Regimen 2Ground-Breaking Combination of All-Oral Agents Demonstrates Potential as Hepatitis C Treatment Regimen 3Ground-Breaking Combination of All-Oral Agents Demonstrates Potential as Hepatitis C Treatment Regimen 4Ground-Breaking Combination of All-Oral Agents Demonstrates Potential as Hepatitis C Treatment Regimen 5Ground-Breaking Combination of All-Oral Agents Demonstrates Potential as Hepatitis C Treatment Regimen 6Ground-Breaking Combination of All-Oral Agents Demonstrates Potential as Hepatitis C Treatment Regimen 7Ground-Breaking Combination of All-Oral Agents Demonstrates Potential as Hepatitis C Treatment Regimen 8Ground-Breaking Combination of All-Oral Agents Demonstrates Potential as Hepatitis C Treatment Regimen 9Ground-Breaking Combination of All-Oral Agents Demonstrates Potential as Hepatitis C Treatment Regimen 10Ground-Breaking Combination of All-Oral Agents Demonstrates Potential as Hepatitis C Treatment Regimen 11Roche and Pharmasset Initiate Phase IIb Clinical Trial of R7128, Most Advanced Nucleoside Polymerase Inhibitor in Development for Chronic Hepatitis C 2Roche and Pharmasset Initiate Phase IIb Clinical Trial of R7128, Most Advanced Nucleoside Polymerase Inhibitor in Development for Chronic Hepatitis C 3Roche and Pharmasset Initiate Phase IIb Clinical Trial of R7128, Most Advanced Nucleoside Polymerase Inhibitor in Development for Chronic Hepatitis C 4Roche and Pharmasset Initiate Phase IIb Clinical Trial of R7128, Most Advanced Nucleoside Polymerase Inhibitor in Development for Chronic Hepatitis C 5Roche and Pharmasset Initiate Phase IIb Clinical Trial of R7128, Most Advanced Nucleoside Polymerase Inhibitor in Development for Chronic Hepatitis C 6Roche and Pharmasset Initiate Phase IIb Clinical Trial of R7128, Most Advanced Nucleoside Polymerase Inhibitor in Development for Chronic Hepatitis C 7Roche and Pharmasset Initiate Phase IIb Clinical Trial of R7128, Most Advanced Nucleoside Polymerase Inhibitor in Development for Chronic Hepatitis C 8Roche and Pharmasset Initiate Phase IIb Clinical Trial of R7128, Most Advanced Nucleoside Polymerase Inhibitor in Development for Chronic Hepatitis C 9Roche and Pharmasset Initiate Phase IIb Clinical Trial of R7128, Most Advanced Nucleoside Polymerase Inhibitor in Development for Chronic Hepatitis C 10
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
Medicine Products: